ADCOCK INGRAM HLDGS LTD 

$3.5
7
+$0+0% Wednesday 13:30

Statistics

Day High
3.5
Day Low
3.5
52W High
3.5
52W Low
2.45
Volume
100
Avg. Volume
0
Mkt Cap
0
P/E Ratio
10.94
Dividend Yield
4.53%
Dividend
0.16

Upcoming

Dividends

4.53%Dividend Yield
Mar 26
$0.06
Sep 25
$0.1
Mar 25
$0.06
Sep 24
$0.09
Mar 24
$0.07
10Y Growth
8.41%
5Y Growth
20.75%
3Y Growth
5.82%
1Y Growth
N/A

Earnings

25FebExpected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q4 2024
Q2 2025
Q4 2025
0
0.05
0.1
0.15
Expected EPS
N/A
Actual EPS
N/A

Financials

8.63%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
801.07MRevenue
69.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AIHLF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson is a global healthcare company that competes with Adcock Ingram in various segments including pharmaceuticals and consumer health products.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a global biopharmaceutical company that competes directly with Adcock Ingram in the pharmaceuticals sector, particularly in the development and marketing of medications.
Novartis
NVS
Mkt Cap297.32B
Novartis is a global healthcare company that competes with Adcock Ingram in the pharmaceuticals and generics sectors, offering a wide range of healthcare products.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline is a global healthcare company that competes with Adcock Ingram in pharmaceuticals, vaccines, and consumer healthcare products.
Merck
MRK
Mkt Cap298.84B
Merck & Co., Inc. is a global healthcare company that competes with Adcock Ingram in the pharmaceuticals sector, particularly in the development of innovative medicines.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie is a global biopharmaceutical company that competes with Adcock Ingram in the development and marketing of pharmaceutical products.
Sanofi
SNY
Mkt Cap116.63B
Sanofi is a global healthcare company that competes with Adcock Ingram in the pharmaceuticals and vaccines sectors, offering a broad range of healthcare solutions.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Adcock Ingram in the development and distribution of prescription pharmaceuticals.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.03B
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company that competes with Adcock Ingram in the generics and specialty medicines sectors.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca is a global biopharmaceutical company that competes with Adcock Ingram in the development and commercialization of prescription medicines, particularly in the oncology, cardiovascular, renal & metabolism, and respiratory sectors.

About

Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over-the-counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides a range of pharmaceutical products, such as women's health, cannabidiol oil, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.
Show more...
CEO
Mr. Andrew Gideon Hall BPharm, CA (SA)
Country
ZA

Listings

0 Comments

Share your thoughts

FAQ

What is ADCOCK INGRAM HLDGS LTD stock price today?
The current price of AIHLF is $3.5 USD — it has increased by +0% in the past 24 hours. Watch ADCOCK INGRAM HLDGS LTD stock price performance more closely on the chart.
What is ADCOCK INGRAM HLDGS LTD stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ADCOCK INGRAM HLDGS LTD stocks are traded under the ticker AIHLF.
What is ADCOCK INGRAM HLDGS LTD revenue for the last year?
ADCOCK INGRAM HLDGS LTD revenue for the last year amounts to 801.07M USD.
What is ADCOCK INGRAM HLDGS LTD net income for the last year?
AIHLF net income for the last year is 69.14M USD.
Does ADCOCK INGRAM HLDGS LTD pay dividends?
Yes, AIHLF dividends are paid semi-annual. The last dividend per share was 0.06 USD. As of today, Dividend Yield (FWD)% is 4.53%.
In which sector is ADCOCK INGRAM HLDGS LTD located?
ADCOCK INGRAM HLDGS LTD operates in the Health Care sector.
When did ADCOCK INGRAM HLDGS LTD complete a stock split?
ADCOCK INGRAM HLDGS LTD has not had any recent stock splits.
Where is ADCOCK INGRAM HLDGS LTD headquartered?
ADCOCK INGRAM HLDGS LTD is headquartered in Midrand, ZA.